Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Rovelli

Showing results (151-160 of 179) with videos related to

Pageof 18
Sort By:
Journal of Biological Regulators and Homeostatic Agents|May 16, 1998
Acute endocrine effects of interleukin-12 in cancer patientsP Lissoni, F Rovelli, M R Rivolta, et al.
Giornale Italiano Di Cardiologia|January 1, 1978
[Sodium nitroprusside in the treatment of severe left ventricular insufficiency in acute myocardial infarct. Personal clinical experience and hemodynamic considerations]M Bossi, G Cataldo, S Pirelli, et al.
Journal of Biological Regulators and Homeostatic Agents|July 1, 1993
Effects of granulocyte-macrophage colony stimulating factor on soluble interleukin-2 receptor serum levels and their relation to neopterin and tumor necrosis factor-alpha in cancer patientsS Crispino, P Lissoni, A Ardizzoia, et al.
Cancer|March 15, 1993
In vitro modulatory effects of interleukin-3 on macrophage activation induced by interleukin-2P Lissoni, S Pittalis, F Brivio, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
In vivo biological results of the association between interleukin-2 and interleukin-3 in the immunotherapy of cancerP Lissoni, S Barni, E Tisi, et al.
The International Journal of Biological Markers|April 1, 1989
Serum levels of soluble interleukin-2 receptors and their relation to CD4/CD8 ratio in patients with advanced solid tumorsG Tancini, P Lissoni, S Barni, et al.
British Journal of Cancer|July 1, 1992
Biological and clinical results of a neuroimmunotherapy with interleukin-2 and the pineal hormone melatonin as a first line treatment in advanced non-small cell lung cancerP Lissoni, E Tisi, S Barni, et al.
In Vivo (Athens, Greece)|August 22, 2007
Immune and endocrine mechanisms of advanced cancer-related hypercortisolemiaP Lissoni, F Brivio, L Fumagalli, et al.
Tumori|June 30, 1987
Correlation between changes in prolactin and melatonin serum levels after radical mastectomyP Lissoni, F Paolorossi, S Barni, et al.
Cancer|August 1, 1988
A study on the relationship between the pineal gland and the opioid system in patients with cancer. Preliminary considerationsD Esposti, P Lissoni, G Tancini, et al.
Pageof 18

Showing results (151-160 of 179) with videos related to

Sort By:
Pageof 18
Journal of Biological Regulators and Homeostatic Agents|May 16, 1998
Acute endocrine effects of interleukin-12 in cancer patientsP Lissoni, F Rovelli, M R Rivolta, et al.
Giornale Italiano Di Cardiologia|January 1, 1978
[Sodium nitroprusside in the treatment of severe left ventricular insufficiency in acute myocardial infarct. Personal clinical experience and hemodynamic considerations]M Bossi, G Cataldo, S Pirelli, et al.
Journal of Biological Regulators and Homeostatic Agents|July 1, 1993
Effects of granulocyte-macrophage colony stimulating factor on soluble interleukin-2 receptor serum levels and their relation to neopterin and tumor necrosis factor-alpha in cancer patientsS Crispino, P Lissoni, A Ardizzoia, et al.
Cancer|March 15, 1993
In vitro modulatory effects of interleukin-3 on macrophage activation induced by interleukin-2P Lissoni, S Pittalis, F Brivio, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
In vivo biological results of the association between interleukin-2 and interleukin-3 in the immunotherapy of cancerP Lissoni, S Barni, E Tisi, et al.
The International Journal of Biological Markers|April 1, 1989
Serum levels of soluble interleukin-2 receptors and their relation to CD4/CD8 ratio in patients with advanced solid tumorsG Tancini, P Lissoni, S Barni, et al.
British Journal of Cancer|July 1, 1992
Biological and clinical results of a neuroimmunotherapy with interleukin-2 and the pineal hormone melatonin as a first line treatment in advanced non-small cell lung cancerP Lissoni, E Tisi, S Barni, et al.
In Vivo (Athens, Greece)|August 22, 2007
Immune and endocrine mechanisms of advanced cancer-related hypercortisolemiaP Lissoni, F Brivio, L Fumagalli, et al.
Tumori|June 30, 1987
Correlation between changes in prolactin and melatonin serum levels after radical mastectomyP Lissoni, F Paolorossi, S Barni, et al.
Cancer|August 1, 1988
A study on the relationship between the pineal gland and the opioid system in patients with cancer. Preliminary considerationsD Esposti, P Lissoni, G Tancini, et al.
Pageof 18